Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 earnings figures before tomorrow’s bell. Given recent price action, a buy-the-dip ...
The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback